Cargando…

Her-2 Expression in Gastroesophageal Intestinal Metaplasia, Dysplasia, and Adenocarcinoma

Overexpression of human epidermal growth factor receptor 2 protein (Her-2) in Barrett neoplasia is significant for targeted therapy with trastuzumab. Here, we studied the frequency of Her-2 overexpression in Barrett adenocarcinoma and precursor lesions. Retrospective formalin-fixed paraffin-embedded...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almhanna, Khaldoun, Rosa, Marilin, Henderson-Jackson, Evita, Jiang, Kun, Shamekh, Rania, Sayegh, Zena, Malafa, Mokenge P., Coppola, Domenico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771552/ https://www.ncbi.nlm.nih.gov/pubmed/26186253 http://dx.doi.org/10.1097/PAI.0000000000000243

Ejemplares similares

Treatment for metastatic adenocarcinoma of the stomach and gastroesophageal junction: 2020
por: Hsu, Andrew, et al.
Publicado: (2020)

Editorial for the series on gastric and gastroesophageal cancer treatment in 2020
por: Almhanna, Khaldoun
Publicado: (2020)

Targeted therapies for gastroesophageal cancers
por: Hsu, Andrew, et al.
Publicado: (2020)

Pembrolizumab for the treatment of patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction cancer: an evidence-based review of place in therapy
por: Mehta, Rutika, et al.
Publicado: (2018)

Farnesyl dimethyl chromanol targets colon cancer stem cells and prevents colorectal cancer metastasis
por: Husain, Kazim, et al.
Publicado: (2021)

Beyond Chemotherapy, PD-1, and HER-2: Novel Targets for Gastric and Esophageal Cancer
por: Siddiqui, Ali Zubair, et al.
Publicado: (2021)

Interleukin-17 Expression in the Barrett's Metaplasia-Dysplasia-Adenocarcinoma Sequence
por: Bannister, J. R., et al.
Publicado: (2012)

Does tumor profile in gastric and gastroesophageal (GE) junction cancer justify off-label use of targeted therapy?—a narrative review
por: Del Prete, Christopher, et al.
Publicado: (2020)

Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia–dysplasia–adenocarcinoma sequence
por: Griffiths, E A, et al.
Publicado: (2007)

HER-2/neu Testing and Therapy in Gastroesophageal Adenocarcinoma
por: Moelans, Cathy B., et al.
Publicado: (2010)

Progress and challenges in HER2-positive gastroesophageal adenocarcinoma
por: Zhao, Dan, et al.
Publicado: (2019)

Polypoidal Intestinal Metaplasia and Dysplasia of the External Urethral Meatus
por: Mathew, Mary, et al.
Publicado: (2012)

Gastric intestinal metaplasia is associated with gastric dysplasia but is inversely correlated with esophageal dysplasia
por: Gomez, Justin M, et al.
Publicado: (2017)

Microsatellite instability in metaplasia-dysplasia-adenocarcinoma sequence of Barrett esophagus: a retrospective study
por: Markoš, Pave, et al.
Publicado: (2018)

Isolated Splenic Metastases of Her2+++ Gastroesophageal Junction Adenocarcinoma
por: Sigrand, Julie, et al.
Publicado: (2016)

δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer metastasis
por: Husain, Kazim, et al.
Publicado: (2017)

Evolving management of metaplasia and dysplasia in Barrett's epithelium
por: Evans, Richard P T, et al.
Publicado: (2016)

Phase Ib/II study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) and tremelimumab as monotherapy or in combination, in patients with recurrent or metastatic gastric/gastroesophageal junction adenocarcinoma
por: Kelly, Ronan J, et al.
Publicado: (2015)

Targeting the IκB Kinase Enhancer and Its Feedback Circuit in Pancreatic Cancer()
por: Challa, Sridevi, et al.
Publicado: (2020)

Digital Image Analysis of HER2 Immunostained Gastric and Gastroesophageal Junction Adenocarcinomas
por: Nielsen, Sofie L., et al.
Publicado: (2017)

CDX1 and CDX2 Expression in Intestinal Metaplasia, Dysplasia and Gastric Cancer
por: Kang, Jung Mook, et al.
Publicado: (2011)

TGFβ1 overexpression is associated with improved survival and low tumor cell proliferation in patients with early-stage pancreatic ductal adenocarcinoma
por: Glazer, Evan S., et al.
Publicado: (2016)

Case report: Irreversible electroporation for locally advanced pancreatic cancer
por: Orcutt, Sonia, et al.
Publicado: (2017)

Recurrent intestinal metaplasia at the gastroesophageal junction following endoscopic eradication of dysplastic Barrett’s esophagus may not be benign
por: Cameron, Georgina R., et al.
Publicado: (2016)

Large rib osteochondroma in a child in Aleppo, Syria
por: Alhames, Samer, et al.
Publicado: (2018)

Locoregional gastric cancer: a narrative review of multidisciplinary management
por: Pelcovits, Ari, et al.
Publicado: (2020)

Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma
por: Cheong, E. Von, et al.
Publicado: (2021)

Narrow Band Imaging for the Detection of Gastric Intestinal Metaplasia and Dysplasia During Surveillance Endoscopy
por: Capelle, Lisette G., et al.
Publicado: (2010)

Liquid nitrogen spray cryotherapy for intramucosal carcinoma and extensive gastric intestinal metaplasia with dysplasia
por: Harris, Spencer, et al.
Publicado: (2021)

Safety and efficacy of HER2 blockade by trastuzumab-based chemotherapy-containing combination strategies in HER2+ gastroesophageal adenocarcinoma
por: Catenacci, D.V.T., et al.
Publicado: (2021)

Minimally invasive appendectomy for resection of appendiceal mucocele: Case series and review of the literature
por: Orcutt, Sonia T., et al.
Publicado: (2017)

Regulation of Gastric Metaplasia, Dysplasia, and Neoplasia by Bone Morphogenetic Protein Signaling
por: Todisco, Andrea
Publicado: (2017)

Safety and efficacy of sorafenib in the treatment of hepatocellular carcinoma
por: Almhanna, Khaldoun, et al.
Publicado: (2009)

Mucin histochemistry of stomach in metaplasia and adenocarcinoma: An observation
por: Mandal, Prakas Kumar, et al.
Publicado: (2013)

Impact of HER2 status in resected gastric or gastroesophageal junction adenocarcinoma in a Western population
por: Lago, Nieves Martínez, et al.
Publicado: (2020)

Synergistic Effects of Metformin and Trastuzumab on HER2 Positive Gastroesophageal Adenocarcinoma Cells In Vitro and In Vivo
por: Kim, Jin-Soo, et al.
Publicado: (2023)

Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma
por: Zhou, Zhongren, et al.
Publicado: (2019)

Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review
por: Spence, Andrew D., et al.
Publicado: (2017)

Murine Pancreatic Adenocarcinoma Reduces Ikaros Expression and Disrupts T Cell Homeostasis
por: Nelson, Nadine, et al.
Publicado: (2015)

Apoptotic activity is increased in parallel with the metaplasia–dysplasia–carcinoma sequence of the bronchial epithelium
por: Törmänen, U, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_34nuh9ohv79sacq8s6v3hhq1ok